featured
Effects of Combined RAAS-Inhibitor and Beta-Blocker Treatment on Outcomes in HFrEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of Combined Renin-Angiotensin-Aldosterone System Inhibitor and Beta-Blocker Treatment on Outcomes in Heart Failure With Reduced Ejection Fraction: Insights From BIOSTAT-CHF and ASIAN-HF Registries
Eur. J. Heart Fail 2020 Jun 25;[EPub Ahead of Print], W Ouwerkerk, TK Teng, J Tromp, WT Tay, JG Cleland, DJ van Veldhuisen, K Dickstein, LL Ng, CC Lang, SD Anker, F Zannad, CL Hung, JPS Sawhney, A Naik, W Shimizu, N Hagiwara, GS Wander, I Anand, AM Richards, AA Voors, CSP LamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.